For Providers

Earlier Insight. Better Decisions. Healthier Patients.

Partner with Kihealth Labs to bring next-generation molecular diagnostics into your practice. Our BetaIntercept™ portfolio provides physicians with advanced biological insight into Type 1 diabetes, Type 2 diabetes, metabolic health, and disease progression through a single blood sample.

Become a Provider Partner Schedule a Scientific Discussion

CLIA molecular laboratory Single blood sample Physician-grade reporting

Physician reviewing laboratory results with a patient

The Next Generation of Metabolic Diagnostics

Traditional metabolic testing often evaluates downstream changes after disease has already progressed. Kihealth's molecular diagnostics platform is designed to evaluate active disease biology and provide physicians with deeper insight into metabolic health across the continuum of care.

Earlier biological insight

Detect active disease biology earlier in the continuum — before traditional markers shift.

Beta cell–focused diagnostics

Direct molecular signals of beta cell stress, injury, and turnover.

Prevention-focused care

Inform interventions earlier, when prevention and modification are most effective.

Longitudinal patient monitoring

Serial testing supports response assessment and long-term metabolic surveillance.

Precision medicine support

Multi-marker panels designed for individualized clinical decision support.

Research-backed innovation

Built on translational science from leading academic and clinical institutions.

Our Diagnostic Portfolio

Two molecular diagnostics. One mission: earlier detection and better metabolic care.

Kihealth Labs has developed two physician-ordered molecular diagnostic panels designed to provide deeper biological insight across the continuum of Type 1 and Type 2 diabetes. Both tests require only a simple venous blood draw and are processed in our CLIA- and COLA-certified high-complexity molecular laboratory.

BetaIntercept™ T1D

Helping identify Type 1 diabetes earlier through comprehensive beta cell biology, autoimmune biomarkers, and advanced molecular diagnostics.

A physician-ordered molecular diagnostic panel designed to provide comprehensive insight into Type 1 diabetes biology and support earlier identification of beta cell injury in pediatric and at-risk populations.

Designed For

Pediatric screening
Type 1 diabetes risk assessment
Earlier identification of beta cell injury
Longitudinal monitoring
Autoimmune disease evaluation
Prevention-focused clinical care

Biomarker Panel

Beta Cell Score™

Comprehensive Autoantibody Panel

Insulin

C-Peptide

HbA1c

Simple Venous Blood Draw

Clinical Workflow

1Simple Venous Blood Draw↓
2Kihealth Molecular Laboratory↓
3Comprehensive Biomarker Analysis↓
4Physician Report

Become a BetaIntercept™ T1D Provider Learn more

BetaIntercept™ T2D

Earlier detection and longitudinal monitoring of Type 2 diabetes through advanced beta cell biology and metabolic biomarker analysis.

A physician-ordered molecular diagnostic panel designed to support earlier identification of metabolic dysfunction, evaluate beta cell health, and enable longitudinal monitoring throughout disease progression and therapeutic intervention.

Designed For

Type 2 diabetes risk assessment
Prediabetes evaluation
Comprehensive metabolic health
Beta cell biology
Longitudinal patient monitoring
Lifestyle intervention monitoring
GLP-1 therapy monitoring
Weight management programs
Employer health programs
Precision metabolic medicine

Biomarker Panel

Beta Cell Score™

Insulin

C-Peptide

HbA1c

Simple Venous Blood Draw

Clinical Workflow

1Simple Venous Blood Draw↓
2Kihealth Molecular Laboratory↓
3Advanced Metabolic Analysis↓
4Physician Report↓
5Longitudinal Monitoring

Become a BetaIntercept™ T2D Provider Learn more

Side by Side

Compare BetaIntercept™ T1D and T2D

Feature	BetaIntercept™ T1D	BetaIntercept™ T2D
Primary focus	Type 1 Diabetes	Type 2 Diabetes
Target population	Pediatric & at-risk patients	Adults with metabolic risk
Beta Cell Score™
Insulin
C-Peptide
HbA1c
Comprehensive autoantibody panel		—
Simple venous blood draw
Longitudinal monitoring
GLP-1 therapy monitoring	—

Clinical venipuncture blood draw with standard collection tubes

Sample Collection

Simple collection. Advanced science.

Both BetaIntercept™ T1D and BetaIntercept™ T2D require only a simple venous blood draw using two standard blood collection tubes. Samples are processed in Kihealth Labs' CLIA- and COLA-certified high-complexity molecular laboratory.

Venous blood draw

2 standard tubes

CLIA + COLA certified

High-complexity lab

BetaIntercept™ T1D

Earlier Insight Into Type 1 Diabetes

A molecular diagnostic platform designed for pediatric screening, Type 1 diabetes risk assessment, earlier detection of beta cell injury, and prevention of late-stage diagnosis.

Pediatric populations

Type 1 diabetes

Autoimmune progression

Earlier detection

Disease interception

Longitudinal monitoring

Clinical research

The Type 1 Diabetes Continuum

Healthy Islets

Genetic Susceptibility

Immune Activation

Autoantibody Development

Beta Cell Stress

Beta Cell Death

Declining Insulin Production

Clinical Type 1 Diabetes

Our goal is to identify disease biology before patients present with advanced disease.

Autoimmune Biomarker Panel

Five validated autoantibody markers covering the breadth of islet autoimmunity.

Molecular Biomarkers

Beta cell biology and metabolic context from a single blood draw.

BetaIntercept™

Proprietary cfDNA assay for beta cell injury.

Cell-Free DNA

Circulating DNA fragments released from injured cells.

Beta Cell Injury

Methylation signal specific to pancreatic beta cells.

Insulin

Endogenous insulin production.

C-Peptide

Surrogate marker of beta cell secretory function.

HbA1c

Three-month glycemic exposure.

BetaIntercept™ T2D

Comprehensive Metabolic Intelligence

A comprehensive molecular and metabolic health panel designed to evaluate beta cell biology, metabolic dysfunction, disease progression, and response to therapeutic intervention.

Clinical Applications

Type 2 Diabetes Prevention

Prediabetes Risk Assessment

Comprehensive Metabolic Health

Beta Cell Monitoring

Lifestyle Intervention Monitoring

GLP-1 Therapy Monitoring

Weight Management Programs

Employer Health Programs

Longevity Medicine

Functional Medicine

Concierge Medicine

Comprehensive Biomarker Dashboard

Physician-facing view across beta cell biology and metabolic context.

Patient · BetaIntercept™ T2D · Visit 03

Illustrative

BetaIntercept™

Marker 1

Active

HbA1c

Marker 2

5.8 %

Insulin

Marker 3

12 µU/mL

C-Peptide

Marker 4

2.1 ng/mL

Glucose

Marker 5

104 mg/dL

Metabolic Panel

Marker 6

Comprehensive

Longitudinal trend: stableDesigned for clinical decision support

GLP-1 Monitoring

Monitor Response to Modern Metabolic Therapies

Serial testing supports physicians in assessing metabolic biology before, during, and after therapeutic intervention. Designed to support longitudinal assessment of metabolic health.

Baseline

GLP-1 Initiation

3 Months

6 Months

Long-Term Monitoring

Who Should Offer BetaIntercept™

Designed for clinicians across the prevention and metabolic care continuum.

Endocrinology

Primary Care

Pediatrics

Family Medicine

Functional Medicine

Integrative Medicine

Obesity Medicine

Concierge Medicine

Longevity Clinics

Employer Health Programs

Ideal Patient Populations

Clinical scenarios where deeper molecular insight changes the conversation.

Family history of diabetes

Pediatric autoimmune risk

Prediabetes

Insulin resistance

Obesity

GLP-1 therapy

Metabolic syndrome

High-risk patients

Wellness optimization

Clinical Laboratory Workflow

From Blood Sample to Molecular Insight

Scientist operating molecular diagnostics instrument

Real CLIA molecular laboratory · Kihealth Labs

Blood Collection

Standard venous draw at the provider's office or partner phlebotomy site.

Specimen Processing

Chain-of-custody intake and accessioning at our CLIA molecular lab.

Plasma Separation

Validated centrifugation protocol preserves cell-free DNA integrity.

Cell-Free DNA Extraction

High-yield extraction optimized for low-input plasma samples.

Digital Droplet PCR

ddPCR enables absolute quantification of beta cell–specific signals.

Molecular Biomarker Analysis

Methylation and cfDNA signatures interpreted against reference cohorts.

Autoimmune Marker Analysis (T1D)

Multi-autoantibody panel for islet-directed immunity.

Metabolic Marker Analysis (T2D)

Beta cell function and metabolic context integrated together.

AI & Pattern Recognition

Models contextualize results against longitudinal patient and population data.

Integrated Clinical Report

A single, physician-friendly report delivered into your workflow.

Designed for Clinical Decision Support

Each BetaIntercept™ report integrates molecular, metabolic, and immunologic context into a single physician-friendly view.

Pediatric / Autoimmune

BetaIntercept™ T1D

Beta cell biology

Section 1

Autoimmune markers

Section 2

Longitudinal trends

Section 3

Metabolic / Adult

BetaIntercept™ T2D

Metabolic biomarkers

Section 1

Beta cell health

Section 2

Insulin resistance

Section 3

Therapy monitoring

Section 4

Illustrative reports for demonstration purposes.

Becoming a Kihealth Provider Partner

A simple, supported pathway from first inquiry to integrated patient testing.

Request Information

Provider Consultation

Account Setup

Ordering Access

Patient Testing

Results Delivery

Clinical Support

Provider Resources

Materials to support your clinical, research, and operational teams.

Product Brochures

White Papers

Scientific Publications

Clinical Evidence

Sample Reports

Ordering Guide

Billing Information

FAQs

Become a Provider Partner

Submit your information and our provider relations team will follow up to set up your account.